Trial intelligence / Profile preview

Evaluation of a statin decision aid tool for people with type 2 diabetes mellitus

2010-023912-14Phase 4Active

Sponsor
Fundación Canaria de Investigación Sanitaria
Start
Jan 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of simvastatin and pravastatin in type 2 diabetes mellitus (T2DM), sponsored by Fundación Canaria de Investigación Sanitaria. Primary endpoints: Use of statins and Adherence to statins. Started Jan 2011; status: active.

02

Drugs

simvastatinpravastatin
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on 2010-023912-14.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-023912-14.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call